Erakusten 1 - 20 emaitzak -- 23 bilaketa honetara 'Miranda D Grounds', Bilaketaren denbora: 0,06s Findu emaitzak
  1. 1
    Article Commentary: Commentary on the Present State of Knowledge for Myoblast Transfer Therapy

    Article Commentary: Commentary on the Present State of Knowledge for Myoblast Transfer Therapy nork Miranda D. Grounds

    Argitaratua 1996-05-01
    Testu osoa
    Artikulua
  2. 2
    Myoblast Transfer Therapy in the New Millennium

    Myoblast Transfer Therapy in the New Millennium nork Miranda D. Grounds

    Argitaratua 2000-07-01
    Testu osoa
    Artikulua
  3. 3
    Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx mice

    Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx mice nork Hannah G. Radley, Miranda D. Grounds

    Argitaratua 2006-08-01
    Testu osoa
    Artikulua
  4. 4
    Exposure to Tissue Culture Conditions Can Adversely Affect Myoblast Behavior in Vivo in Whole Muscle Grafts: Implications for Myoblast Transfer Therapy

    Exposure to Tissue Culture Conditions Can Adversely Affect Myoblast Behavior in Vivo in Whole Muscle Grafts: Implications for Myoblast Transfer Therapy nork Gayle M. Smythe, Miranda D. Grounds

    Argitaratua 2000-05-01
    Testu osoa
    Artikulua
  5. 5
    Why Do Cultured Transplanted Myoblasts Die in Vivo? DNA Quantification Shows Enhanced Survival of Donor Male Myoblasts in Host Mice Depleted of CD4 and CD8 Cells or NK1.1 Cells

    Why Do Cultured Transplanted Myoblasts Die in Vivo? DNA Quantification Shows Enhanced Survival of Donor Male Myoblasts in Host Mice Depleted of CD4 and CD8 Cells or NK1.1 Cells nork Stuart I. Hodgetts, Manfred W. Beilharz, Anthony A. Scalzo, Miranda D. Grounds

    Argitaratua 2000-07-01
    Testu osoa
    Artikulua
  6. 6
    Striking denervation of neuromuscular junctions without lumbar motoneuron loss in geriatric mouse muscle.

    Striking denervation of neuromuscular junctions without lumbar motoneuron loss in geriatric mouse muscle. nork Ruth Jinfen Chai, Jana Vukovic, Sarah Dunlop, Miranda D Grounds, Thea Shavlakadze

    Argitaratua 2011-01-01
    Testu osoa
    Artikulua
  7. 7
    A Blood Biomarker for Duchenne Muscular Dystrophy Shows That Oxidation State of Albumin Correlates with Protein Oxidation and Damage in Mdx Muscle

    A Blood Biomarker for Duchenne Muscular Dystrophy Shows That Oxidation State of Albumin Correlates with Protein Oxidation and Damage in Mdx Muscle nork Basma A. Al-Mshhdani, Miranda D. Grounds, Peter G. Arthur, Jessica R. Terrill

    Argitaratua 2021-08-01
    Testu osoa
    Artikulua
  8. 8
    Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy

    Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy nork Miranda D. Grounds, Hannah G. Radley, Gordon S. Lynch, Kanneboyina Nagaraju, Annamaria De Luca

    Argitaratua 2008-07-01
    Testu osoa
    Artikulua
  9. 9
    Dysferlin-deficiency has greater impact on function of slow muscles, compared with fast, in aged BLAJ mice.

    Dysferlin-deficiency has greater impact on function of slow muscles, compared with fast, in aged BLAJ mice. nork Erin M Lloyd, Hongyang Xu, Robyn M Murphy, Miranda D Grounds, Gavin J Pinniger

    Argitaratua 2019-01-01
    Testu osoa
    Artikulua
  10. 10
    Correction: Dysferlin-deficiency has greater impact on function of slow muscles, compared with fast, in aged BLAJ mice.

    Correction: Dysferlin-deficiency has greater impact on function of slow muscles, compared with fast, in aged BLAJ mice. nork Erin M Lloyd, Hongyang Xu, Robyn M Murphy, Miranda D Grounds, Gavin J Pinniger

    Argitaratua 2023-01-01
    Testu osoa
    Artikulua
  11. 11
    Beneficial effects of high dose taurine treatment in juvenile dystrophic mdx mice are offset by growth restriction.

    Beneficial effects of high dose taurine treatment in juvenile dystrophic mdx mice are offset by growth restriction. nork Jessica R Terrill, Gavin J Pinniger, Keshav V Nair, Miranda D Grounds, Peter G Arthur

    Argitaratua 2017-01-01
    Testu osoa
    Artikulua
  12. 12
    Oxidised Albumin Levels in Plasma and Skeletal Muscle as Biomarkers of Disease Progression and Treatment Efficacy in Dystrophic <i>mdx</i> Mice

    Oxidised Albumin Levels in Plasma and Skeletal Muscle as Biomarkers of Disease Progression and Treatment Efficacy in Dystrophic <i>mdx</i> Mice nork Jessica R. Terrill, Angelo Patrick R. Bautista, Irene Tsioutsias, Miranda D. Grounds, Peter G. Arthur

    Argitaratua 2024-06-01
    Testu osoa
    Artikulua
  13. 13
    MicroRNA and Long Non-coding RNA Regulation in Skeletal Muscle From Growth to Old Age Shows Striking Dysregulation of the Callipyge Locus

    MicroRNA and Long Non-coding RNA Regulation in Skeletal Muscle From Growth to Old Age Shows Striking Dysregulation of the Callipyge Locus nork Jasmine Mikovic, Kate Sadler, Lauren Butchart, Sarah Voisin, Frederico Gerlinger-Romero, Paul Della Gatta, Miranda D. Grounds, Séverine Lamon

    Argitaratua 2018-11-01
    Testu osoa
    Artikulua
  14. 14
    Dystropathology increases energy expenditure and protein turnover in the mdx mouse model of duchenne muscular dystrophy.

    Dystropathology increases energy expenditure and protein turnover in the mdx mouse model of duchenne muscular dystrophy. nork Hannah G Radley-Crabb, Juan C Marini, Horacio A Sosa, Liliana I Castillo, Miranda D Grounds, Marta L Fiorotto

    Argitaratua 2014-01-01
    Testu osoa
    Artikulua
  15. 15
    Dysferlin deficiency alters lipid metabolism and remodels the skeletal muscle lipidome in mice

    Dysferlin deficiency alters lipid metabolism and remodels the skeletal muscle lipidome in mice nork Vanessa R. Haynes, Stacey N. Keenan, Jackie Bayliss, Erin M. Lloyd, Peter J. Meikle, Miranda D. Grounds, Matthew J. Watt

    Argitaratua 2019-08-01
    Testu osoa
    Artikulua
  16. 16
    Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular Dystrophy

    Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular Dystrophy nork Jessica R. Terrill, Marisa N. Duong, Rufus Turner, Caroline Le Guiner, Amber Boyatzis, Anthony J. Kettle, Miranda D. Grounds, Peter G. Arthur

    Argitaratua 2016-10-01
    Testu osoa
    Artikulua
  17. 17
    A Comparison between Real-Time Quantitative PCR and DNA Hybridization for Quantitation of Male DNA following Myoblast Transplantation

    A Comparison between Real-Time Quantitative PCR and DNA Hybridization for Quantitation of Male DNA following Myoblast Transplantation nork Erika Bosio, Tracey F. Lee-Pullen, Clayton T. Fragall, Manfred W. Beilharz, Alayne L. Bennett, Miranda D. Grounds, Stuart I. Hodgetts, Leanne M. Sammels

    Argitaratua 2004-10-01
    Testu osoa
    Artikulua
  18. 18
    Macrophage Depletion in Elderly Mice Improves Response to Tumor Immunotherapy, Increases Anti-tumor T Cell Activity and Reduces Treatment-Induced Cachexia

    Macrophage Depletion in Elderly Mice Improves Response to Tumor Immunotherapy, Increases Anti-tumor T Cell Activity and Reduces Treatment-Induced Cachexia nork Lelinh Duong, Hannah G. Radley-Crabb, Joanne K. Gardner, Federica Tomay, Danielle E. Dye, Miranda D. Grounds, Fiona J. Pixley, Delia J. Nelson, Connie Jackaman

    Argitaratua 2018-11-01
    Testu osoa
    Artikulua
  19. 19
    Ageing contributes to phenotype transition in a mouse model of periodic paralysis

    Ageing contributes to phenotype transition in a mouse model of periodic paralysis nork Karen J. Suetterlin, S. Veronica Tan, Roope Mannikko, Rahul Phadke, Michael Orford, Simon Eaton, Avan A. Sayer, Miranda D. Grounds, Emma Matthews, Linda Greensmith, Michael G. Hanna

    Argitaratua 2021-07-01
    Testu osoa
    Artikulua
  20. 20
    Muscle Pathology in Dystrophic Rats and Zebrafish Is Unresponsive to Taurine Treatment, Compared to the <i>mdx</i> Mouse Model for Duchenne Muscular Dystrophy

    Muscle Pathology in Dystrophic Rats and Zebrafish Is Unresponsive to Taurine Treatment, Compared to the <i>mdx</i> Mouse Model for Duchenne Muscular Dystrophy nork Jessica R. Terrill, Corinne Huchet, Caroline Le Guiner, Aude Lafoux, Dorian Caudal, Ankita Tulangekar, Robert J. Bryson-Richardson, Tamar E. Sztal, Miranda D. Grounds, Peter G. Arthur

    Argitaratua 2023-02-01
    Testu osoa
    Artikulua

Bilaketa egiteko lanabesak: